Search

everythinglearnresearchcommunity

for

Search:↓

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Monoclonal antibodies are often linked to alopecia areata cases.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Lamotrigine can cause hair loss in some patients.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Immunotherapy can help treat severe alopecia areata.

JAK inhibitors are effective treatments for alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

The hydrogel effectively treats oral mucositis by reducing oxidative damage and bacterial infection.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.